Bourla pledged that Pfizer will maintain its dividend even in the most stretched scenarios and resume growing it after the loss-of-exclusivity period.
We feel extremely confident that, even in the most stretched scenarios that we are running, we will be able to maintain our dividend. I want once and for all to make that clear to all: the dividend will be maintained and, after the LOE period, will start growing again.